
Robert S. Cabral
Examiner (ID: 18249, Phone: (571)270-3769 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618, 1614 |
| Total Applications | 949 |
| Issued Applications | 549 |
| Pending Applications | 83 |
| Abandoned Applications | 341 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19165827
[patent_doc_number] => 11981714
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-14
[patent_title] => CCR5 and CD4 siRNA-targeted phospholipid nanosomes therapeutics for treatment of HIV-1 and other diseases
[patent_app_type] => utility
[patent_app_number] => 17/096738
[patent_app_country] => US
[patent_app_date] => 2020-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9681
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17096738
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/096738 | CCR5 and CD4 siRNA-targeted phospholipid nanosomes therapeutics for treatment of HIV-1 and other diseases | Nov 11, 2020 | Issued |
Array
(
[id] => 16806122
[patent_doc_number] => 20210128675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => LHRH-PACLITAXEL CONJUGATES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/085957
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20135
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17085957
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/085957 | LHRH-PACLITAXEL CONJUGATES AND METHODS OF USE | Oct 29, 2020 | Abandoned |
Array
(
[id] => 16806121
[patent_doc_number] => 20210128674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => LHRH-CONJUGATED PRODIGIOSIN AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/085861
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20243
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17085861
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/085861 | LHRH-CONJUGATED PRODIGIOSIN AND USES THEREOF | Oct 29, 2020 | Abandoned |
Array
(
[id] => 16809444
[patent_doc_number] => 20210131998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => GAS SENSOR NANOCOMPOSITE MEMBRANES
[patent_app_type] => utility
[patent_app_number] => 17/083465
[patent_app_country] => US
[patent_app_date] => 2020-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5672
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17083465
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/083465 | GAS SENSOR NANOCOMPOSITE MEMBRANES | Oct 28, 2020 | Abandoned |
Array
(
[id] => 17889832
[patent_doc_number] => 11452779
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-27
[patent_title] => Fluorescein and benoxinate compositions
[patent_app_type] => utility
[patent_app_number] => 17/079375
[patent_app_country] => US
[patent_app_date] => 2020-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 29
[patent_no_of_words] => 60615
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17079375
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/079375 | Fluorescein and benoxinate compositions | Oct 22, 2020 | Issued |
Array
(
[id] => 18034477
[patent_doc_number] => 20220378692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => TREATMENT OF PANCREATIC CANCER
[patent_app_type] => utility
[patent_app_number] => 17/755221
[patent_app_country] => US
[patent_app_date] => 2020-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18727
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17755221
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/755221 | TREATMENT OF PANCREATIC CANCER | Oct 22, 2020 | Pending |
Array
(
[id] => 16619864
[patent_doc_number] => 20210038517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => DICARBOXYLIC ACID FOAMABLE VEHICLE AND PHARMACEUTICAL COMPOSITIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/072243
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24060
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17072243
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/072243 | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof | Oct 15, 2020 | Issued |
Array
(
[id] => 16749007
[patent_doc_number] => 20210101016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => Magnetic Microwires for Energy-Transporting Biomedical Applications
[patent_app_type] => utility
[patent_app_number] => 17/066418
[patent_app_country] => US
[patent_app_date] => 2020-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11254
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17066418
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/066418 | Magnetic microwires for energy-transporting biomedical applications | Oct 7, 2020 | Issued |
Array
(
[id] => 17082076
[patent_doc_number] => 20210277082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => METHODS AND COMPOSITIONS FOR INCREASING RED BLOOD CELLS
[patent_app_type] => utility
[patent_app_number] => 17/063848
[patent_app_country] => US
[patent_app_date] => 2020-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063848
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/063848 | Methods and compositions for increasing red blood cells | Oct 5, 2020 | Issued |
Array
(
[id] => 16596713
[patent_doc_number] => 20210023244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => SUBLINGUAL AND BUCCAL ADMINISTRATIONS OF FLUORESCENT AGENTS FOR OPTICAL IMAGING
[patent_app_type] => utility
[patent_app_number] => 17/035490
[patent_app_country] => US
[patent_app_date] => 2020-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17035490
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/035490 | SUBLINGUAL AND BUCCAL ADMINISTRATIONS OF FLUORESCENT AGENTS FOR OPTICAL IMAGING | Sep 27, 2020 | Abandoned |
Array
(
[id] => 20270815
[patent_doc_number] => 12440581
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Fluorophores for super-resolution imaging
[patent_app_type] => utility
[patent_app_number] => 17/027286
[patent_app_country] => US
[patent_app_date] => 2020-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 67
[patent_no_of_words] => 16972
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 420
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17027286
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/027286 | Fluorophores for super-resolution imaging | Sep 20, 2020 | Issued |
Array
(
[id] => 20270815
[patent_doc_number] => 12440581
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Fluorophores for super-resolution imaging
[patent_app_type] => utility
[patent_app_number] => 17/027286
[patent_app_country] => US
[patent_app_date] => 2020-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 67
[patent_no_of_words] => 16972
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 420
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17027286
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/027286 | Fluorophores for super-resolution imaging | Sep 20, 2020 | Issued |
Array
(
[id] => 18034740
[patent_doc_number] => 20220378955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => RADIOLABELING OF ANTI-CD45 IMMUNOGLOBULIN AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/761579
[patent_app_country] => US
[patent_app_date] => 2020-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761579
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/761579 | RADIOLABELING OF ANTI-CD45 IMMUNOGLOBULIN AND METHODS OF USE THEREOF | Sep 16, 2020 | Pending |
Array
(
[id] => 16671425
[patent_doc_number] => 20210060188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => TCO CONJUGATES AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/018314
[patent_app_country] => US
[patent_app_date] => 2020-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11115
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17018314
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/018314 | TCO conjugates and methods for delivery of therapeutic agents | Sep 10, 2020 | Issued |
Array
(
[id] => 16513038
[patent_doc_number] => 20200392296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => Nano coordination polymer and preparation method and application thereof
[patent_app_type] => utility
[patent_app_number] => 17/006785
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17006785
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/006785 | Nano coordination polymer and preparation method and application thereof | Aug 27, 2020 | Abandoned |
Array
(
[id] => 17895487
[patent_doc_number] => 20220305149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => NOVEL THERANOSTIC AGENTS FOR PSMA POSITIVE CANCERS
[patent_app_type] => utility
[patent_app_number] => 17/638512
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10619
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638512
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/638512 | NOVEL THERANOSTIC AGENTS FOR PSMA POSITIVE CANCERS | Aug 27, 2020 | Pending |
Array
(
[id] => 16466822
[patent_doc_number] => 20200368359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => REDUCED AND OXIDIZED POLYSACCHARIDES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/992385
[patent_app_country] => US
[patent_app_date] => 2020-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32038
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16992385
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/992385 | Reduced and oxidized polysaccharides and methods of use thereof | Aug 12, 2020 | Issued |
Array
(
[id] => 16548621
[patent_doc_number] => 10881760
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-01-05
[patent_title] => Antioxidant, antibacterial, injectable lignin-gelatin composite cryogels for wound healing and tissue engineering
[patent_app_type] => utility
[patent_app_number] => 16/989088
[patent_app_country] => US
[patent_app_date] => 2020-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4074
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16989088
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/989088 | Antioxidant, antibacterial, injectable lignin-gelatin composite cryogels for wound healing and tissue engineering | Aug 9, 2020 | Issued |
Array
(
[id] => 17850618
[patent_doc_number] => 20220280659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => Targeted Nanoparticles of Well-Defined and Reproducible Sizes
[patent_app_type] => utility
[patent_app_number] => 17/633536
[patent_app_country] => US
[patent_app_date] => 2020-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17633536
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/633536 | Targeted Nanoparticles of Well-Defined and Reproducible Sizes | Aug 3, 2020 | Abandoned |
Array
(
[id] => 17850618
[patent_doc_number] => 20220280659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => Targeted Nanoparticles of Well-Defined and Reproducible Sizes
[patent_app_type] => utility
[patent_app_number] => 17/633536
[patent_app_country] => US
[patent_app_date] => 2020-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17633536
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/633536 | Targeted Nanoparticles of Well-Defined and Reproducible Sizes | Aug 3, 2020 | Abandoned |